Abstract
Bladders of anaesthetised mice were illuminated with laser light of 630 nm at 24 h after intraperitoneal administration of the photosensitiser Photofrin II (10 mg kg-1). A range of light doses, at a power setting of 100 mW, was delivered intravesically by a fibre optic inserted into the centre of the bladder via the urethra. Functional bladder damage was assessed from increases in urination frequency and the presence of urethra. Functional bladder damage was assessed from increases in urination frequency and the presence of haematuria at 1 to 26 weeks after treatment. Whole bladder illumination with incident light doses exceeding 18.75 J cm-2 caused extensive oedema, haemorrhage and necrosis of the bladder wall and mice had to be sacrificed within 24 h. PDT with incident light doses of 3.75 to 15.0 J cm-2 caused haematuria and increased urination frequency during the first week in nearly all mice, but there was complete functional recovery by 6 to 10 weeks after doses of up to 7.5 J cm-2. Recovery was slower after higher doses and up to 50% of mice still had some increased urination frequency at 10 weeks after greater than or equal to 11.25 J cm-2, although haematuria was rare at this time. Histologically, early damage (one day after PDT) consisted of epithelial sloughing, submucosal oedema, fibrin imbibition, vascular ectasia and, rarely, thrombosis. Doses exceeding 7.5 J cm-2 were often associated with foci of necrosis. In some instances, necrosis was complicated by bacterial infection, resulting in an acute transmural inflammation with a tendency to suppuration. After doses of up to 11.25 J cm-2 there was a gradual recovery and only a mild degree of fibrosis of the bladder wall (with some increase in vascularity) remained at 6 months.
Highlights
Small numbers of mice were treated with light doses of up to 37.5 J cm-2 at 24 h after 10 mg kg- ' Photofrin II
There was no sign of haemorrhage or necrosis of the intestine
All animals treated with 37.5 J cm-2 alone or Photofrin II alone remained healthy and without significant weight loss
Summary
Integral PDT can be achieved by instilling a light scattering medium into the bladder (Jocham et al, 1984; Jocham, 1987) or with the use of special isotropic light sources with a diffuser 'light bulb' tip (Benson, 1985; Nseyo et al, 1985; Star et al, 1987; Marijnissen et al, 1989). Preliminary results from ongoing clinical studies indicate a good response, for CIS. Follow-up of patients treated with whole bladder illumination PDT is still relatively short and there is a lack of information regarding long term normal tissue toxicity. Many aspects of PDT, such as optimal timing of light delivery and optimal light and sensitiser doses, have still to be defined to achieve a good tumour response without unacceptable bladder damage
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.